循环白细胞介素-6水平与新发缺血性卒中:前瞻性研究的系统综述与荟萃分析
该系统综述与荟萃分析纳入11项前瞻性队列研究(27411人,2669例卒中事件),发现循环log转换IL-6水平每升高1个标准差,新发缺血性卒中风险增加19%(RR 1.19,95%CI 1.10-1.28),呈线性剂量反应关系,且独立于传统血管危险因素。
要点
- 循环IL-6水平每升高1个标准差,新发缺血性卒中风险增加19%(RR 1.19,95%CI 1.10-1.28)。
- 剂量反应荟萃分析显示IL-6水平与缺血性卒中风险呈线性关联。
- 关联独立于传统血管危险因素,敏感性分析结果一致。
核心结论
- 社区人群循环IL-6水平较高与新发缺血性卒中长期风险较高相关,呈线性模式,且独立于传统血管危险因素。
研究设计与样本
- 遵循PRISMA指南,系统检索PubMed从建库至2021年3月,纳入基于人群的前瞻性队列研究,采用随机效应模型合并关联估计值,并进行剂量反应荟萃分析。
- 共纳入11项研究,27411名个体,2669例卒中事件;平均年龄60.5岁,女性占54.8%。
- 采用纽卡斯尔-渥太华量表(NOS)评估偏倚风险,中位8分(四分位距7-9)。
主要发现
- 循环log转换IL-6水平每升高1个标准差,平均随访12.4年期间新发缺血性卒中风险增加19%(相对风险1.19;95%置信区间1.10至1.28)。
- 剂量反应荟萃分析显示循环IL-6水平与缺血性卒中风险呈线性关联。
- 异质性仅为中等,限制于低偏倚风险研究和完全校正人口学及血管危险因素研究的敏感性分析结果一致。
- 校正发表偏倚后结果仍稳定。
局限性
- 异质性仅为中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Human genetic studies support a key role of interleukin-6 (IL-6) in the pathogenesis of ischemic stroke. However, there are only limited data from observational studies exploring circulating IL-6 levels as a risk factor for ischemic stroke. We set out to perform a systematic review and meta-analysis of aggregate data on cohort studies to determine the magnitude and shape of the association between circulating IL-6 levels and risk of incident ischemic stroke in the general population. METHODS: Following the PRISMA guidelines, we systematically screened the PubMed search engine from inception to March 2021 for population-based prospective cohort studies exploring the association between circulating IL-6 levels and risk of incident ischemic stroke. We pooled association estimates for ischemic stroke risk with random-effects models and explored nonlinear effects in dose-response meta-analyses. Risk of bias was assessed with the Newcastle-Ottawa Scale (NOS). We used funnel plots and trim-to-fill analyses to assess publication bias. RESULTS: We identified 11 studies (n = 27,411 individuals; 2,669 stroke events) meeting our eligibility criteria. Mean age of all included participants was 60.5 years and 54.8% were female. Overall, quality of the included studies was high (median 8 out of 9 NOS points, interquartile range 7-9). In meta-analyses, 1 SD increment in circulating log-transformed IL-6 levels was associated with a 19% increase in risk of incident ischemic stroke over a mean follow-up of 12.4 years (relative risk 1.19; 95% confidence interval 1.10 to 1.28). A dose-response meta-analysis showed a linear association between circulating IL-6 levels and ischemic stroke risk. There was only moderate heterogeneity and the results were consistent in sensitivity analyses restricted to studies of low risk of bias and studies fully adjusting for demographic and vascular risk factors. The results also remained stable following adjustment for publication bias. DISCUSSION: Higher circulating IL-6 levels in community-dwelling individuals are associated with higher long-term risk of incident ischemic stroke in a linear pattern and independently of conventional vascular risk factors. Along with findings from genetic studies and clinical trials, these results provide additional support for a key role of IL-6 signaling in ischemic stroke.
引用
- Papadopoulos A, Palaiopanos K, Björkbacka H, et al. Circulating Interleukin-6 Levels and Incident Ischemic Stroke: A Systematic Review and Meta-analysis of Prospective Studies. Neurology. 2021. PMID: 34969940. doi:10.1212/WNL.0000000000013274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。